Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives $47.46 Average Price Target from Brokerages
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) has received an average rating of “Buy” from the fifteen research firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. The […]
